Prostate Health Market Size Projected To Reach 53.25 Billion By 2034 With A Cagr Of 9.3%

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Projected Growth of the Prostate Health Market?
The market size for prostate health has seen a significant surge in growth recently. The increase from $34.07 billion in 2024 to $37.34 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.6%, alludes to this fact. The growth during the historic period could be credited to factors such as the rising elderly population, amplified PSA screening, growth in awareness campaigns, hormonal therapy advancements, and increasing incidence rates.

In the coming years, the prostate health market is predicted to experience significant growth. The market size is set to reach $53.25 billion in 2029, growing at a compounded annual growth rate of 9.3%. This expansion during the forecast period is attributed to various factors including the broader adoption of precision medicine, increased reliance on AI-powered diagnostic tools, the growth of targeted radiotherapy techniques, heightened demand for minimally invasive procedures, and improved genetic profiling for risk determination. Key trends that we could witness during this forecast period include the use of AI for risk assessment, development in liquid biopsy techniques, emerging innovations in radiotheranostics and immunotherapy, as well as advancement in real-time biomarker monitoring.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265

What Are the Different Prostate Health Market Segments?
The prostate health market covered in this report is segmented -

1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels

Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp

What Are the Primary Drivers Shaping the Prostate Health Market?
The surge in prostate cancer instances is anticipated to boost the expansion of the prostate health market. Prostate cancer transpires when cells in the prostate gland proliferate out of control, often emerging as adenocarcinomas, men's most frequent form of this illness. The uptick in the occurrence of prostate cancer is chiefly attributable to the augmenting aging populace, intensified screening measures, and lifestyle aspects such as obesity and sedentary behavior. Improving prostate health is crucial for the prevention, early identification, and treatment of prostate cancer. For instance, the American Cancer Society (ACS), a non-profit organization based in the U.S., reported a prediction of roughly 288,300 new prostate cancer cases being discovered in the U.S. in 2023, causing an anticipated 34,700 deaths. Hence, the growing instance of prostate cancer will spur the expansion of the prostate health market.

Which Companies Are Leading in the Prostate Health Market?
Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.

What Are the Major Trends Shaping the Prostate Health Market?
Leading companies in the prostate health market are concentrating on technological progress, such as AI-driven risk evaluation, to stay ahead of their competitors. These AI-driven tools use machine learning algorithms to sift through data and predict potential hazards, assisting in the decision-making process and enhancing results. As an example, Nanostics Inc., a clinical-stage biotechnology company from Canada, and Protean BioDiagnostics, a biotech firm from the US, collaborated in September 2024 to launch CDX Prostate. This diagnostic tool, designed for men at risk of developing aggressive prostate cancer, combines biological data, clinical information, and AI-enabled training models to calculate a risk score. CDX Prostate deploys advanced machine learning algorithms to interpret diverse biological and clinical data, offering a more precise risk score for aggressive prostate cancer than conventional methods. This evaluation assists health care practitioners and patients in making an informed decision about proceeding with a biopsy in the event of a high prostate-specific antigen (PSA) test result or an unusual digital rectal exam (DRE).

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report

What Are the Top Revenue-Generating Geographies in the Prostate Health Market?
North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prostate Health Market?
2. What is the CAGR expected in the Prostate Health Market?
3. What Are the Key Innovations Transforming the Prostate Health Industry?
4. Which Region Is Leading the Prostate Health Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.